As Medicines Co. seeks funding, Denner brings in new CEO

The Medicines Company (NASDAQ: MDCO) said Tuesday it hired Mark Timney as CEO and a director, succeeding long-running CEO Clive Meanwell. The announcement comes after activist investor Alex Denner became chairman in June, and follows the biotech's news that it needs additional funding to develop inclisiran.

"With [Timney's] hiring, the board continues to focus on execution, accountability and maximizing shareholder value," Denner said in a statement...